Efficacy of urine bile acid as a non-invasive indicator of liver damage in rats

Journal of Toxicological Sciences

Volumn 34, Issue 1, 2009, Pages 27-38

  Kawai, Hiroshi ^a   Kudo, Naomi ^b   Kawashima, Yoichi ^b   Mitsumoto, Atsushi ^a  

^a JOSAI INTERNATIONAL UNIVERSITY   (Japan)

^b JOSAI UNIVERSITY   (Japan)

Author keywords

Bile acid; Cholestasis; Cirrhosis; Liver; Thioacetamide; Urine

Indexed keywords

ALKALINE PHOSPHATASE; BILE ACID;

ACUTE DRUG ADMINISTRATION; ACUTE HEPATITIS; ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE ACID BLOOD LEVEL; CHOLESTASIS; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DISEASE DURATION; DISEASE MODEL; DOSE RESPONSE; ENZYME ACTIVITY; LIVER CIRRHOSIS; LIVER HISTOLOGY; LIVER INJURY; LIVER TUMOR; MALE; NONHUMAN; PREDICTIVE VALIDITY; RAT; SCREENING; SENSITIVITY AND SPECIFICITY; URINALYSIS;

ANIMALIA; RATTUS;

EID: 59949104431     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.34.27     Document Type: Article

References (53)

1. Albrecht, J. and Jones, E.A. (1999): Hepatic encephalopathy: molecular mechanisms underlying the clinical syndrome. J. Neurol. Sci., 170, 138-146.
2. Almé, B., Bremmelgaard, A., Sjövall, J. and Thomassen, P. (1977): Analysis of metabolic profiles of bile acids in urine using a lipophilic anion exchanger and computerized gas-liquid chroma-tography-mass spectrometry. J. Lipid Res., 18, 339-362.
3. Angelin, B., I. Björkhem, I., Einarsson, K. and Ewerth, S. (1982): Hepatic uptake of bile acids in man: fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum. J. Clin. Invest., 70, 724-731.
4. Balkman, C.E., Center, S.A., Randolph, J.F., Trainor, D., Warner, K.L., Crawford, M.A., Adachi, K. and Erb, H.N. (2003): Evaluation of urine sulfated and nonsulfated bile acids as a diagnostic test for liver disease in dogs. J. Am. Vet. Med. Assoc., 222, 1368-1375.
5. Barker, E.A. and Smuckler, E.A. (1974): Nonhepatic thioacetamide injury. II. The morphologic features of proximal renal tubular injury. Am. J. Pathol. 74, 575-590.
6. Batta, A.K., Arora, R., Salen, G., Tint, G.S., Eskreis, D. and Katz, S. (1989): Characterization of serum and urinary bile acids in patients with primary biliary cirrhosis by gas-liquid chromatog-raphy-mass spectrometry: effect of ursodeoxycholic acid treatment. J. Lipid Res., 30, 1953-1962.
7. Blei, A.T., Córdoba, J. and Practice Parameters Committee of the American College of Gastroenterology. (2001): Hepatic Encephalopathy. Am. J. Gastroenterol., 96, 1968-1976.
8. Bruckner, J.V., Ramanathan, R., Lee, K.M. and Muralidhara, S. (2002): Mechanisms of circadian rhythmicity of carbon tetrachloride hepatotoxicity. J. Pharmacol. Exp. Ther., 300, 273-281.
9. Chen, J., Terada, T., Ogasawara, K., Ktsura, T. and Inui, K. (2008): Adaptive responses of renal organic anion transporter 3 (OAT3) during cholestasis. Am. J. Physiol. Renal Physiol., 295, 247-252.
10. Chiang, J.Y (1998): Regulation of bile acid synthesis. Front. Biosci., 3, 176-193.
11. Chilakapati, J., Korrapati, M.C., Shankar, K., Hill, R.A., Warbritton, A., Latendresse, J.R. and Mehendale, H.M. (2007): Role of CYP2E1 and saturation kinetics in the bioactivation of thioacetamide: Effects of diet restriction and phenobarbital. Toxicol. Appl. Pharmacol., 219, 72-84.
12. Dashti, H., Jeppsson, B., Hägerstrand, I., Hultberg, B., Srinivas, U., Abdulla, M. and Bengmark, S. (1989): Thioacetamide-and carbon tetrachloride-induced liver cirrhosis. Eur. Surg. Res., 21, 83-91.
13. Dawson, P.A. (2002): Bile secretion and the enterohepatic circulation of bile acids. In Gastrointestinal and Liver Disease (Feldman, M., Friedman, L.S., Sleisenger, M.H., ed.), pp.1051-1064, WB Saunders Co., St. Louis.
14. Ferenci, P., Lockwood, A., Mullen, K., Tarter, R., Weissenborn, K. and Blei, A.T. (2002): Hepatic encephalopathy-defmition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology, 35, 716-721.
15. Fontana, L., Moreira, E., Torres, M.I., Fernandez, M.I., Rios, A., De Medina, F.S. and Gil, A. (1996): Serum amino acid changes in rats with thioacetamide-induced liver cirrhosis. Toxicology, 106, 197-206.
16. Galeazzi, R. and Javitt, N. (1977): Bile acid excretion: the alternate pathway in the hamster. J. Clin. Invest., 60, 693-701.
17. Geier, A., Dietrich, C.G., Gerloff, T., Haendly, J., Kullak-Ublick, G.A., Stieger, B., Meier, P.J., Matern, S. and Gartung, C. (2003): Regulation of basolateral organic anion transporters in ethi-nylestradiol-induced cholestasis in the rat. Biochim. Biophys. Acta, 1609, 87-94.
18. Gupta, D.N. (1955): Production of cancer of the bile ducts with thioacetamide. Nature, 175, 257.
19. Haider, S., Saleem, S., Shameem, S., Ahmed, S.P., Parveen, T. and Haleem, D.J. (2004): Is anorexia in thioacetamide-induced cir-rhosis related to an altered brain serotonin concentration? Pol. J. Pharmacol., 56, 73-78.
20. Hazell, A.S. and Butterworth, R.F. (1999): Hepatic encephalopathy: An update of pathophysiologic mechanisms. Proc. Soc. Exp. Biol. Med., 222, 99-112.
21. Ho, K.J. and Drummond, J.L. (1975): Circadian rhythm of biliary excretion and its control mechanisms in rats with chronic biliary drainage. Am. J. Physiol., 229, 1427-1437.
22. Hofmann, A. (2007): Biliary secretion and excretion in health and disease: current concepts. Ann. Hepatol., 6, 15-27.
23. Huang, W.M., Seubert, D.E., Donnelly, J.G., Liu, M. and Javitt, N.B. (2007): Intrahepatic cholestasis of pregnancy: detection with urinary bile acid assays. J. Perinatal Med., 35, 486-491.
24. LaRusso, N.F., Hoffman, N.E., Korman, M.G., Hofmann, A.F. and Cowen, A.E. (1978): Determinants of fasting and postprandial serum bile acid levels in healthy man. Am. J. Dig. Dis., 23, 385-391.
25. Lee, J., Azzaroli, F., Wang, L., Soroka, C.J., Gigliozzi, A., Setchell, K.D.R., Kramer, W. and Boyer, J.L. (2001): Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology, 121, 1473-1484.
26. Makino, I., Shinozaki, K., Nakagawa, S. and Mashimo, K. (1974): Measurement of sulfated and nonsulfated bile acids in human serum and urine. J. Lipid Res., 15, 132-138.
27. Mangipudy, R.S., Chanda, S. and Mehendale H.M. (1995): Tissue repair response as a function of dose in thioacetamide hepatotoxicity. Environ. Health Perspect. 103, 260-267.
28. Matsui, A., Kasano, Y., Yamauchi, Y, Momoya, T., Shimada, T., Ishikawa, T., Abukawa, D., Kimura, A., Adachi, K. and Tazuke, Y. (1996): Direct enzymatic assay of urinary sulfated bile acids to replace serum bilirubin testing for selective screening of neonatal cholestasis. J. Pediatr., 129, 306-308.
29. Matsunaga, N., Nakamura, N., Yoneda, N., Qin, T., Terazono, H., To, H., Higuchi, S. and Ohdo, S. (2004): Influence of feeding schedule on 24-h rhythm of hepatotoxicity induced by acetaminophen in mice. J. Pharmacol. Exp. Ther., 311, 594-600.
30. Méndez, M., Méndez-López, M., López, L., Áller, M.A., Árias, J., Cimadevilla, J.M. and Árias, J.L. (2008): Spatial memory alterations in three models of hepatic encephalopathy. Behav. Brain Res., 188, 32-40.
31. Moreira, E., Fontana, L., Periago, J.-L., De Medina, F.S. and Gil, A. (1995): Changes in fatty acid composition of plasma, liver microsomes, and erythrocytes in liver cirrhosis induced by oral intake of thioacetamide in rats. Hepatology, 21, 199-206.
32. Müller, A., Machnik, F., Zimmermann, T. and Schubert, H. (1988): Thioacetamide-induced cirrhosis-like liver lesions in rats--usefulness and reliability of this animal model. Exp. Pathol., 34, 229-236.
33. Nakano, A., Tietz, P.S. and LaRusso, N.F. (1990): Circadian rhythms of biliary protein and lipid excretion in rats. Am. J. Physiol. Gastrointest. Liver Physiol., 258, 653-659.
34. Nakao, K., Ohhara, H., Taki, T., Wakabayashi, T. and Ohgoh, T. (1980): Hepatotoxic effects of lithocholic acid and sulfolithocholic acid in rabbits. Yakugaku Zasshi, 100, 792-798.
35. Obatake, M., Muraji, T., Satoh, S., Nishijima, E. and Tsugawa, C. (2002): Urinary sulfated bile acids: a new simple urine test for cholestasis in infants and children. J. Pediatr. Surg., 37, 1707-1708.
36. Palmer, R.H. (1967): The formation of bile acid sulfates: a new pathway of bile acid metabolism in humans. PNAS, 58, 1047-1050.
37. Palmer, R.H. (1971): Bile acid sulfates. II. Formation, metabolism, and excretion of lithocholic acid sulfates in the rat. J. Lipid Res., 12, 680-687.
38. Ramaiah, S. K., Apte, U. and Mehendale, H.M. (2001): Cytochrome P4502E1 induction increases thioacetamide liver injury in diet-restricted rats. Drug Metab. Dispos. 29, 1088-1095.
39. Rudman, D. and Kendall, F.E. (1957): Bile Acid Content of Human Serum. I. Serum Bile Acids in Patients with Hepatic Disease. J. Clin. Invest., 36, 530-537.
40. Ruiz, M.L., Villanueva, S.S.M., Luquita, M.G., Vore, M., Mottino, A.D. and Catania, V.A. (2006): Ethynylestradiol increases expression and activity of rat liver Mrp3. Drug Metab. Dispos., 34, 1030-1034.
41. Sato, M., Kakubari, M., Kawamura, M., Sugimoto, J. Matsumoto, K. and Ishii, T. (2000): The decrease in total collagen fibers in the liver by hepatocyte growth factor after formation of cirrhosis induced by thioacetamide. Biochem. Pharmacol., 59, 681-690.
42. Schwenk, M., Hofmann, A.F., Carlson, G.L., Carter, J.A., Coulston, F. and Greim, H. (1978): Bile acid conjugation in the chimpanzee: effective sulfation of lithocholic acid. Arch. Toxicol., 40, 109-118.
43. Shinohara, T., Muraji, T., Tsugawa, C., Nishijima, E., Satoh, S. and Takamizawa, S. (2005) Efficacy of urinary sulfated bile acids for diagnosis of bacterial cholangitis in biliary atresia. Pediatr. Surg. Int., 21, 701-704.
44. Shoda, J., Tanaka, N., Osuga, T., Matsuura, K. and Miyazaki, H. (1990): Altered bile acid metabolism in liver disease: concurrent occurrence of C-1 and C-6 hydroxylated bile acid metabolites and their preferential excretion into urine. J. Lipid Res., 31, 249-259.
45. Simko, V., Michael, S. and Kelley, R.E. (1987): Predictive value of random sample urine bile acids corrected by creatinine in liver disease. Hepatology, 7, 115-121.
46. Stiehl, A. (1974): Bile Salt Sulphates in Cholestasis. Eur. J. Clin. Invest., 4, 59-63.
47. Summerfield, J., Billing, B.H. and Shackleton, C.H. (1976): Identification of bile acids in the serum and urine in cholestasis. Evidence for 6alpha-hydroxylation of bile acids in man. Biochem. J., 154, 507-516.
48. Suzuki, H., Hamada, M. and Kato, F. (1985): Metabolism of litho-cholic and chenodeoxycholic acids in the squirrel monkey. Gastroenterology, 89, 631-636.
49. Takita, M., Ikawa, S. and Ogura, Y. (1988): Effect of Bile Duct Ligation on Bile Acid and Cholesterol Metabolism in Rats. J. Biochem., 103, 778-786.
50. Trainor, D., Center, S.A., Randolph, J.E., Balkman, C.E., Warner, K.L., Crawford, M.A., Adachi, K. and Erb, H.N. (2003): Urine Sulfated and Nonsulfated Bile Acids as a Diagnostic Test for Liver Disease in Cats. J. Veter. Int. Med., 17, 145-153.
51. van Berge Henegouwen, G.P., Brandt, K.-H., Eyssen, H. and Par-mentier, G. (1976): Sulphated and unsulphated bile acids in serum, bile, and urine of patients with cholestasis. Gut, 17, 861-869.
52. Vos, T.A., Hooiveld, G.J.E.J., Koning, H., Childs, S., Meijer, D.K.F., Moshage, H., Jansen, P.L.M. and Müller, M. (1998): Up-regu-lation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology, 28, 1637-1644.
53. Yeh, C.N., Maitra, A., Lee, K.F., Jan, Y.Y. and Chen, M.F. (2004): Thioacetamide-induced intestinal-type cholangiocarcinoma in rat: an animal model recapitulating the multi-stage progression of human cholangiocarcinoma. Carcinogenesis, 25, 631-636.